Recombinant Human Anti-DENV x Anti-CD64 Bispecific Antibody (CrossMab) (CROSSAB-H314)

Recombinant Anti-DENV x Anti-CD64 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget neutrophils cells to dengue virus. It is designed for the research of Dengue virus infection therapy.

Datasheet INQUIRY

Specifications

Targets

DENV & CD64

Type

CrossMab

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Dengue virus infection

Targets

Target 1

DENV

Alternative Names

dengue virus; DENV; dengue fever; Flavivirus

Target 2

CD64

Gene ID

2209

UniProt ID

P12314

Alternative Names

FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-DENV x Anti-CD64 Bispecific Antibody (CrossMab) (CROSSAB-H314). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-DENV x Anti-CD64 Bispecific Antibody (CrossMab) (CAT#: CROSSAB-H314)

Specifications

Targets

Customer Reviews and Q&As